Tacrolimus is the most important drug in current posttransplant immunosuppressive protocol. Salt-losing nephropathy causing symptomatic hyponatremia as an adverse effect of tacrolimus has been rarely reported. We report recurrent hyponatremia and graft dysfunction in a young renal transplant recipient, with no evidence of rejection, attributable to. tacrolimus-induced salt-wasting nephropathy.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11044655 | PMC |
| http://dx.doi.org/10.4103/ijn.ijn_351_22 | DOI Listing |
Publication Analysis
Top Keywords
symptomatic hyponatremia
8
salt-losing nephropathy
8
transplant recipient
8
hyponatremia tacrolimus-induced
4
tacrolimus-induced salt-losing
4
nephropathy kidney
4
kidney transplant
4
recipient tacrolimus
4
tacrolimus drug
4
drug current
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!